"But at same time if test group and placebo group were miles apart than the trial would have been stopped / intervened to get things fast-tracked. Like to think worst case scenario was there were indications of potential benefits, that physicians saw no reason to stop treatment due to an excellent safety profile and patients and their families may have thought its worth the shot as there were no other options around"
That's a credible point of view, but I find it hard to believe that so many people - the majority of the trialists and their carers , the physicians, consultants and Prana - would be bothered with another 12 months of funding, travel, taking pills, doing complex tests etc unless there were very compelling reasons for doing so.
Logic tells me that it would have to be more than 'oh well, its safe at least and there's nothing else so lets keep going for a while longer and see what turns up'
PBT Price at posting:
$1.16 Sentiment: LT Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)